To compare the adverse effects of therapy with tumour necrosis factor blocker -etanercept (Enbrel), adalimumab (Humira), infliximab (Remicade), golimumab (Simponi) and certolizumab (Cimzia) -interleukin (IL)-1 antagonist -anakinra (Kineret) -IL-6 antagonist -tocilizumab (RoActemra) -anti
No takes yet. Share an insight, caveat, or question.
A 2011 study studied this question.